Novartis’ Ligelizumab (QGE031) Receives the US FDA’s Breakthrough Designation for Patients with Chronic Spontaneous Urticaria Published: Jan 15, 2020 | Tags: Novartis, ligelizumab, (QGE031), Receives, US, FDA, Breakthrough designation, chronic […]readmore
Tags : Bluebird
Philips Launches QuickClear Mechanical Thrombectomy System for Blood Clot Removal Published: Sept 25,2020 | Tags: Philips, Launches, QuickClear Mechanical Thrombectomy System, Blood Clot Removal 2. BMS Reports Results of Opdivo […]readmore
Shots: Bluebird and Gritstone collaborated to research, develop and commercialize products to treat multiple cancer using cell therapies. Gritstone will provide 10 tumor-specific targets and T-cell receptors (TCRs) in certain […]readmore